These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35110458)

  • 1. Immunohistochemical features of canine ovarian papillary adenocarcinoma and utility of cell block technique for detecting neoplastic cells in body cavity effusions.
    Kita C; Chambers JK; Tanabe M; Irie M; Yamasaki H; Uchida K
    J Vet Med Sci; 2022 Mar; 84(3):406-413. PubMed ID: 35110458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
    Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
    [No Abstract]   [Full Text] [Related]  

  • 3. The cell tube block technique and an immunohistochemistry panel including Wilms tumor 1 to assist in diagnosing cavitary effusions in dogs and cats.
    Marcos R; Marrinhas C; Malhão F; Canadas A; Santos M; Caniatti M
    Vet Clin Pathol; 2019 Mar; 48(1):50-60. PubMed ID: 30865320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine ovarian tumors: an immunohistochemical study with HBME-1 antibody.
    Banco B; Antuofermo E; Borzacchiello G; Cossu-Rocca P; Grieco V
    J Vet Diagn Invest; 2011 Sep; 23(5):977-81. PubMed ID: 21908358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
    Chen CJ; Chang SC; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
    El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
    Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
    Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
    Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical diagnosis of canine ovarian epithelial and granulosa cell tumors.
    Riccardi E; Grieco V; Verganti S; Finazzi M
    J Vet Diagn Invest; 2007 Jul; 19(4):431-5. PubMed ID: 17609358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant effusion of chromophobe renal-cell carcinoma: cytological and immunohistochemical findings.
    Teresa P; Grazia ZM; Doriana M; Irene P; Michele S
    Diagn Cytopathol; 2012 Jan; 40(1):56-61. PubMed ID: 22180239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous Pleural Effusion in a Dog with a Pulmonary Adenocarcinoma and Carcinomatosis.
    Tropf M; Sellon R; Paulson K; Nelson D
    J Am Anim Hosp Assoc; 2015; 51(5):311-4. PubMed ID: 26355581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of adenocarcinoma from canine pleural fluid on aerobic bacterial culture.
    Dusick AF; Bach JF; Liao PT; Hartmann FA
    J Vet Diagn Invest; 2020 Jan; 32(1):156-158. PubMed ID: 31744399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine ovarian epithelial tumours: histopathological and immunohistochemical evaluation with proposed histopathological classification system.
    Dolenšek T; Knific T; Ramírez GA; Erles K; Mallon HE; Priestnall SL; Suárez-Bonnet A
    J Comp Pathol; 2024 Jul; 212():42-50. PubMed ID: 38986425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic features and diagnostic accuracy of analysis of effusions for detection of ovarian carcinoma in dogs.
    Bertazzolo W; Bonfanti U; Mazzotti S; Gelain ME
    Vet Clin Pathol; 2012 Mar; 41(1):127-32. PubMed ID: 22250601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
    Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
    Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.